Retatrutide 5mg + Cagrilintide 5mg Blend
extensively-studiedResearch blend of Retatrutide and Cagrilintide. RaysunPeptide manufactures and supplies Retatrutide 5mg + Cagrilintide 5mg Blend for qualified research, laboratory, and B2B applications.
This product is a research blend combining Retatrutide (5mg) and Cagrilintide (5mg). Retatrutide is a triple receptor agonist (GLP-1/GIP/Glucagon), while Cagrilintide is an amylin analog. This combination is provided for comparative laboratory research on metabolic pathways. RaysunPeptide supplies this blend for qualified research and laboratory applications only.
Mechanism of Action
Triple agonist (GLP-1/GIP/glucagon) combined with amylin analog for enhanced metabolic effects.
Molecular Data
Side Effects & Safety
FAQs
What is Retatrutide 5mg + Cagrilintide 5mg Blend?
Research blend of Retatrutide and Cagrilintide. It has been studied in preclinical and laboratory research settings.
Does RaysunPeptide provide COA for Retatrutide 5mg + Cagrilintide 5mg Blend?
Yes, a Certificate of Analysis is available upon request for each batch.
What specifications are available?
Retatrutide 5mg + Cagrilintide 5mg Blend is available in 10mg configurations.
